EP2403497A4 - Compounds, compositions and use for anticancer therapy - Google Patents

Compounds, compositions and use for anticancer therapy

Info

Publication number: EP2403497A4
Authority: EP; European Patent Office
Prior art keywords: compositions; compounds; anticancer therapy; anticancer; therapy
Prior art date: 2009-03-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP10748321.6A

Other languages

German (de)

French (fr)

Other versions

EP2403497A1 (en

Inventor

Ming Yu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-01

Filing date

2010-03-01

Publication date

2014-01-22

2010-03-01 Application filed by Individual filed Critical Individual

2012-01-11 Publication of EP2403497A1 publication Critical patent/EP2403497A1/en

2014-01-22 Publication of EP2403497A4 publication Critical patent/EP2403497A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP10748321.6A 2009-03-01 2010-03-01 Compounds, compositions and use for anticancer therapy Withdrawn EP2403497A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15650709P	2009-03-01	2009-03-01
PCT/CN2010/070813 WO2010099731A1 (en)	2009-03-01	2010-03-01	Compounds, compositions and use for anticancer therapy

Publications (2)

Publication Number	Publication Date
EP2403497A1 EP2403497A1 (en)	2012-01-11
EP2403497A4 true EP2403497A4 (en)	2014-01-22

Family

ID=42709220

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP10748321.6A Withdrawn EP2403497A4 (en)	2009-03-01	2010-03-01	Compounds, compositions and use for anticancer therapy

Country Status (4)

Country	Link
EP (1)	EP2403497A4 (en)
CN (1)	CN102438620A (en)
AU (1)	AU2010220755B2 (en)
WO (1)	WO2010099731A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3045169B1 (en)	2013-09-13	2018-05-02	Akiko Itai	Aqueous solution formulation, and manufacturing method for same
TWI794161B (en) *	2016-03-07	2023-03-01	美商米托控製藥公司	Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss, and/or metabolic diseases
CN108752477A (en) *	2018-06-19	2018-11-06	上海赛群生物科技有限公司	Application of the tNOX antibody and combinations thereof in preparing tumour cell drug
CN110115712A (en) *	2019-07-04	2019-08-13	兰州大学	Activator that is a kind of while activating oxidative phosphorylation access and inhibition glycolytic pathway and its application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040132004A1 (en) *	2003-01-06	2004-07-08	Jun Nakamura	Method of detecting DNA single strand breaks
US20060189680A1 (en) *	2005-01-31	2006-08-24	Bing-Hua Jiang	Apigenin for chemoprevention, and chemotherapy combined with therapeutic reagents
WO2009006555A2 (en) *	2007-07-02	2009-01-08	Yu, Ming	Methods, composition, targets for combinational cancer treatments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070212360A1 (en) *	2006-01-17	2007-09-13	Denko Nicholas C	Modulation of mitochondrial oxygen consumption for therapeutic purposes

2010
- 2010-03-01 CN CN2010800187658A patent/CN102438620A/en active Pending
- 2010-03-01 EP EP10748321.6A patent/EP2403497A4/en not_active Withdrawn
- 2010-03-01 AU AU2010220755A patent/AU2010220755B2/en not_active Ceased
- 2010-03-01 WO PCT/CN2010/070813 patent/WO2010099731A1/en active Application Filing

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040132004A1 (en) *	2003-01-06	2004-07-08	Jun Nakamura	Method of detecting DNA single strand breaks
US20060189680A1 (en) *	2005-01-31	2006-08-24	Bing-Hua Jiang	Apigenin for chemoprevention, and chemotherapy combined with therapeutic reagents
WO2009006555A2 (en) *	2007-07-02	2009-01-08	Yu, Ming	Methods, composition, targets for combinational cancer treatments

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2010099731A1 *

Also Published As

Publication number	Publication date
WO2010099731A1 (en)	2010-09-10
AU2010220755A1 (en)	2011-10-27
AU2010220755B2 (en)	2013-08-22
CN102438620A (en)	2012-05-02
EP2403497A1 (en)	2012-01-11

Publication	Publication Date	Title
IL242999B (en)	2019-05-30	Pyrazolopyrimidine compounds, pharmaceutical compositions comprising thereof and uses thereof
ZA201200054B (en)	2013-10-30	Therapeutic compounds and compositions
GB0909680D0 (en)	2009-07-22	Dosage form
AP3250A (en)	2015-05-31	Tablets for combination therapy
ZA201101900B (en)	2012-08-29	Therapeutic compositions containing macitentan
IL216388A0 (en)	2012-01-31	New compounds, pharmaceutical composition and methods relating thereto
GB0808835D0 (en)	2008-06-18	Therapeutic compositions
GB0819958D0 (en)	2008-12-10	Therapeutic compositions
IL212375A0 (en)	2011-06-30	Naphthamides as anticancer agents
EP2544542A4 (en)	2013-07-24	Analgesic compounds, compositions, and uses thereof
EP2403497A4 (en)	2014-01-22	Compounds, compositions and use for anticancer therapy
GB0900484D0 (en)	2009-02-11	Therapeutic agent
IL208001A0 (en)	2010-12-30	Improved anticancer treatments
GB0915319D0 (en)	2009-10-07	Combination medicament
IL213445A0 (en)	2011-07-31	Anticancer compounds
PL2263454T3 (en)	2017-07-31	Treatment composition
GB0916997D0 (en)	2009-11-11	Combination therapy
GB0900786D0 (en)	2009-03-04	Therapeutic compositions
EP2460524A4 (en)	2012-12-26	Medicinal composition for iontophoresis
EP2490704A4 (en)	2013-04-03	Therapeutic composition
GB0907973D0 (en)	2009-06-24	Combination therapy
EP2474325A4 (en)	2013-01-16	Drug composition for angiogenesis therapy
GB201010608D0 (en)	2010-08-11	Compounds, compositions and use
GB0908537D0 (en)	2009-06-24	Compositions for treating tumours
GB0814469D0 (en)	2008-09-10	Treatment for tumours

Legal Events

Date	Code	Title	Description
2011-12-09	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2012-01-11	17P	Request for examination filed	Effective date: 20110923
2012-01-11	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
2012-06-06	DAX	Request for extension of the european patent (deleted)
2014-01-22	A4	Supplementary search report drawn up and despatched	Effective date: 20140107
2014-01-22	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 45/06 20060101ALI20131219BHEP Ipc: A61K 31/41 20060101AFI20131219BHEP Ipc: A61K 31/498 20060101ALI20131219BHEP Ipc: A61P 35/00 20060101ALI20131219BHEP Ipc: A61K 31/352 20060101ALI20131219BHEP Ipc: A61K 31/353 20060101ALI20131219BHEP
2015-04-17	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2015-05-20	18D	Application deemed to be withdrawn	Effective date: 20140805